NPI Portal NPI Lookup & Verification

Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum

Synapse Therapeutics Inc

Community/Retail Pharmacy in Glendale, CA · enumerated 2005 · authorized official Arthur Avetisyan, Ceo/Sec/Cfo/Dir/President.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1225026594

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)
Legal business name Synapse Therapeutics Inc
Other name <Unavail>
Practice address 501 Western Ave, Glendale, CA, 91201
Phone (818) 242-5887
Fax (818) 507-6324
Enumeration date Oct 11, 2005
Last updated in NPPES Oct 10, 2023

Taxonomy & classification

3336C0003X Community/Retail Pharmacy Suppliers Primary

Authorized official

Name Arthur Avetisyan
Title Ceo/Sec/Cfo/Dir/President
Phone (818) 242-5887

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

What is the NPI number for Synapse Therapeutics Inc?
The NPI for Synapse Therapeutics Inc is 1225026594, a Type 2 (organization) record in the CMS NPPES registry.
Who is the authorized official for Synapse Therapeutics Inc?
NPPES lists Arthur Avetisyan (Ceo/Sec/Cfo/Dir/President) as the authorized official for this organization.

Providers at this address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2023-10-10.